Iterum Therapeutics plc (ITRM) Financial Statements (2023 and Earlier)

Company Profile

Business Address FITZWILLIAM COURT, 1ST FLOOR
DUBLIN 2, D02 YW24
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments81,34414,5084,80184,551
Cash and cash equivalents27,44614,5084,80144,551
Short-term investments53,898  40,000
Restricted cash and investments 603030
Receivables3656475317
Prepaid expense6806466191,359
Deferred costs  2,339 
Other undisclosed current assets8776,1943,8546,714
Total current assets:83,26621,47211,71892,971
Noncurrent Assets
Property, plant and equipment91421572700
Intangible assets, net (including goodwill)3,435   
Intangible assets, net (excluding goodwill)3,435   
Restricted cash and investments642486090
Other noncurrent assets4,65310,65113,4014,110
Total noncurrent assets:8,24311,32014,0334,900
TOTAL ASSETS:91,50932,79225,75197,871
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,2642,74728,14411,200
Accounts payable87881615,4864,041
Accrued liabilities1,1651,82912,4587,046
Taxes payable221102200113
Debt1,6276,3745,8001,019
Derivative instruments and hedges, liabilities6,05828,865  
Other liabilities2,9923,5983,042 
Other undisclosed current liabilities 114  
Total current liabilities:12,94141,69836,98612,219
Noncurrent Liabilities
Long-term debt and lease obligation10,36627,6347,62513,079
Long-term debt, excluding current maturities6,93022,4627,62513,079
Operating lease, liability3,4365,172 
Liabilities, other than long-term debt3,4365,8027,378951
Other liabilities3,4365,8027,378951
Other undisclosed noncurrent liabilities14,5328,217  
Total noncurrent liabilities:28,33441,65315,00314,030
Total liabilities:41,27583,35151,98926,249
Stockholders' equity
Stockholders' equity attributable to parent50,234(50,559)(26,238)71,622
Common stock1,827494149144
Additional paid in capital426,900235,876208,536203,271
Accumulated deficit(378,493)(286,929)(234,923)(131,793)
Total stockholders' equity:50,234(50,559)(26,238)71,622
TOTAL LIABILITIES AND EQUITY:91,50932,79225,75197,871

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues  37869
Gross profit:  37869
Operating expenses(24,537)(32,126)(102,058)(77,428)
Operating loss:(24,537)(32,126)(102,021)(76,559)
Nonoperating expense(66,322)(19,137)(665)(25)
Other nonoperating income195213196401
Interest and debt expense 340  
Other undisclosed loss from continuing operations before equity method investments, income taxes (340)  
Loss from continuing operations before income taxes:(90,859)(51,263)(102,686)(76,584)
Income tax expense(705)(743)(444)(472)
Net loss available to common stockholders, diluted:(91,564)(52,006)(103,130)(77,056)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(91,564)(52,006)(103,130)(77,056)
Comprehensive loss, net of tax, attributable to parent:(91,564)(52,006)(103,130)(77,056)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: